We implemented a streamlined the process of gaining NHS permission for research studies by reducing bureaucracy but retaining governance, oversight and accountability.
The mission of The Clatterbridge Cancer Centre is to ‘improve health and wellbeing through compassionate, safe and effective cancer care’. The delivery of research for patient benefit is fundamental to our vision to ‘provide the best cancer care to the people that we serve’. The National Institute for Health Research (NIHR) and the Department of Health are increasingly challenging NHS Trusts to deliver ‘faster and easier’ clinical research. We provide proportionate, robust governance to assure compliance with legislation combined with a proactive, rapid delivery of research studies through the NHS permission process that supports the goals of the North West Coast Clinical Research Network (NWC CRN) enabling the NIHR targets and set High Level Objectives (HLOs).
We have a centralised, fully integrated governance system for study set-up and oversight; enabling accurate, real time reporting on study progression and recruitment to time and target using the Edge Platform customised for CCC use.
We implemented a streamlined the process of gaining NHS permission for research studies by reducing bureaucracy but retaining governance, oversight and accountability. The process is shown in the diagram below.
The Research Management and Governance Team assure robust, rapid set up of studies and are available for help, advice and enquires on all aspects of study management:
Lorraine Broadfoot, Research Partnerships Manager
David Price, Governance & Quality Manager
Jane Knight, Trial Facilitator
Doug Elkin, Approvals Facilitator